[{"Assets_0_Q3_USD":4554100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":132559356.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":135109291.0,"StockholdersEquityConverted_0_Q3_USD":1068400000.0,"StockholdersEquity_0_Q3_USD":1068400000.0,"RevenuesConverted_3_Q3_USD":1778100000.0,"RevenuesConverted_1_Q3_USD":627900000.0,"RevenuesConverted_2_Q3_USD":95700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":133123679.0,"NetIncomeLossConverted_3_Q3_USD":900000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":271200000.0,"EarningsPerShareDiluted_3_Q3_USD":0.01,"EarningsPerShareDiluted_1_Q3_USD":0.14,"EarningsPerShareBasic_3_Q3_USD":0.01,"EarningsPerShareBasic_1_Q3_USD":0.14,"CommonStockSharesOutstanding_0_Q3_shares":133369281.0,"CommonStockSharesConverted_0_Q3_shares":133369281.0,"NetIncomeLossConverted_1_Q3_USD":19000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":130577726.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20180501"}]